Molecure (WAR:MOC) Interest Expense: zł-0.04 Mil (TTM As of Sep. 2025)


WAR:MOC Molecure SA WAR:MOC
29 GF Score
Price zł5.97
! 3 Warning Signs
View Full Analysis

What is Molecure Interest Expense?

Molecure WAR:MOC -1.16% 29 Interest Expense is zł-0.04 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Molecure's interest expense for the three months ended in Sep. 2025 was zł -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was zł-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Molecure's Operating Income for the three months ended in Sep. 2025 was zł -5.45 Mil. Molecure's Interest Expense for the three months ended in Sep. 2025 was zł -0.03 Mil. Molecure did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Molecure  (WAR:MOC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Molecure's Interest Expense for the three months ended in Sep. 2025 was zł-0.03 Mil. Its Operating Income for the three months ended in Sep. 2025 was zł-5.45 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2025 was zł3.53 Mil.

Molecure's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

Molecure did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Molecure Interest Expense Historical Data

* Premium members only.

The historical data trend for Molecure's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Interest Expense Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.00 -0.12 -0.09 -0.09

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.01 -0.01 -0.00 -0.03
WAR:MOC
29GF Score
Molecure SA WAR:MOC
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of zł-0.04 Mil mean?
Molecure (WAR:MOC) has a Interest Expense of zł-0.04 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Molecure and its competitors.
Is Molecure's Interest Expense too high?
Molecure's current Interest Expense is zł-0.04 Mil. Overall, Molecure has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Interest Expense compare to VRTX and REGN?
Molecure's Interest Expense of zł-0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Molecure and its competitors. Molecure's current Interest Expense is zł-0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Interest Expense of zł-0.04 Mil. The current Interest Expense is zł-0.04 Mil. Molecure's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Interest Expense is zł-0.04 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
29GF Score

Get the complete analysis for WAR:MOC

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł5.97
Price